Emerging news story: FDA reverses itself on plasma transfusions for COVID-19

I had to reschedule Biscuit’s latest message tonight in order to address a more pressing issue. Three days ago, I wrote about the FDA’s refusal to approve convalescent plasma infusions as a treatment for COVID-19. This afternoon, the FDA seemingly reversed itself and provided Emergency Use Approval (EUA) for using this approach to treat individuals acutelyContinue reading “Emerging news story: FDA reverses itself on plasma transfusions for COVID-19”